While the presence of different tau forms in the CSF of AD patients is associated with neurofibrillary tangle pathology and cognitive decline [18, 29, 50, 64, 74, 90, 116], it is currently unclear whether the tau present in CSF is functionally active and could therefore modulate neural activity. The gene discussed is MAPT; the disease is Mental deterioration.